Home › Trial NCT03710421
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma
- Trial IDNCT03710421
- StatusSuspended
- PhasePhase 1
- Study typeInterventional
- SponsorCity of Hope Medical Center
- Enrollment30
- Start date2019-04-23
- ConditionsRecurrent Plasma Cell Myeloma · Refractory Plasma Cell Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.